A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
      Google Scholar   
Citation:
Urology vol 69 (2) 289-94
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
CA-15083, CA-25224, CA-35101, CA-35103, CA-35113, CA-35119, CA-35195, CA-35267, CA-35269, CA-37404, CA-37417, CA-52352, CA-60276, CA-63826  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N0351
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Administration, Oral, Aged, Aged, 80 and over, Androgens, Anticarcinogenic Agents, Biopsy, Needle, Carotenoids, Complementary Therapies, Dietary Supplements, Follow-Up Studies, Humans, Lycopersicon esculentum, Male, Middle Aged, Neoplasm Staging, Neoplasms, Hormone-Dependent, Patient Selection, Probability, Prostate-Specific Antigen, Prostatic Neoplasms, Risk Assessment, Treatment Outcome